We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Coherus Oncology
CHRS
$217M
| $162K | ﹤0.01% |
67,578
-93,547
| -58% | -$230K |
|
3677
AngioDynamics
ANGO
$562M
| $161K | ﹤0.01% |
27,494
-7,406
| -21% | -$44K |
|
3678
AN2 Therapeutics
ANTX
$177M
| $161K | ﹤0.01% |
+49,607
| New | +$540K |
|
3679
Werewolf Therapeutics
HOWL
$20.8M
| $159K | ﹤0.01% |
+24,594
| New | +$143K |
|
3680
HF Foods Group
HFFG
$83.2M
| $159K | ﹤0.01% |
45,428
+30,580
| +206% | +$134K |
|
3681
Cato Corp
CATO
$65.9M
| $159K | ﹤0.01% |
27,472
-20,757
| -43% | -$139K |
|
3682
INmune Bio
INMB
$43.1M
| $158K | ﹤0.01% |
+13,441
| New | +$162K |
|
3683
CALL
Lightspeed Commerce
LSPD
$1.3B
| $157K | ﹤0.01% |
+11,200
| New | +$178K |
|
3684
Ocular Therapeutix
OCUL
$1.86B
| $157K | ﹤0.01% |
17,297
+3,353
| +24% | +$23.8K |
|
|
MREO
3685
Mereo BioPharma
MREO
$45.9M
| $157K | ﹤0.01% |
+47,687
| New | +$161K |
|
|
LAC
3686
Lithium Americas
LAC
$986M
| $156K | ﹤0.01% |
+23,203
| New | +$121K |
|
3687
GoodRx Holdings
GDRX
$1B
| $156K | ﹤0.01% |
+21,937
| New | +$145K |
|
3688
ASP Isotopes
ASPI
$487M
| $156K | ﹤0.01% |
+37,669
| New | +$116K |
|
3689
Aqua Metals
AQMS
$9.63M
| $155K | ﹤0.01% |
1,441
+945
| +191% | +$106K |
|
|
ICAD
3690
DELISTED
iCAD Inc
ICAD
| $155K | ﹤0.01% |
96,003
+35,084
| +58% | +$55.6K |
|
|
CCC
3691
CCC Intelligent Solutions
CCC
$3.42B
| $154K | ﹤0.01% |
12,905
-311,543
| -96% | -$3.55M |
|
3692
Zymeworks
ZYME
$1.68B
| $154K | ﹤0.01% |
+14,608
| New | +$162K |
|
|
EXK
3693
Endeavour Silver
EXK
$2.32B
| $153K | ﹤0.01% |
+63,490
| New | +$113K |
|
|
AIOT
3694
PowerFleet Inc
AIOT
$500M
| $151K | ﹤0.01% |
+28,314
| New | +$95.9K |
|
3695
PUT
Lucid Motors
LCID
$2.46B
| $150K | ﹤0.01% |
5,280
-52,740
| -91% | -$1.68M |
|
3696
CALL
ChargePoint
CHPT
$133M
| $150K | ﹤0.01% |
3,955
-38,995
| -91% | -$1.53M |
|
3697
Manitowoc
MTW
$516M
| $150K | ﹤0.01% |
10,575
-78,124
| -88% | -$1.16M |
|
3698
SoundHound AI
SOUN
$2.68B
| $148K | ﹤0.01% |
25,183
-140,118
| -85% | -$555K |
|
3699
P3 Health Partners
PIII
$32M
| $148K | ﹤0.01% |
2,875
+374
| +15% | +$20.8K |
|
3700
Sable Offshore Corp
SOC
$903M
| $148K | ﹤0.01% |
+13,490
| New | +$159K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.